Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Peptidic Inhibitors of the Hepatitis C Virus Serine Protease within Non- Structural Protein 3

Author(s): T. O. Fischmann and P. C. Weber

Volume 8, Issue 28, 2002

Page: [2533 - 2540] Pages: 8

DOI: 10.2174/1381612023392595

Price: $65

Abstract

New treatments for HCV (Hepatitis C virus) infections are likely to arise from inhibition of the essential, virally-encoded enzymes. These targets include the serine protease required for processing of the HCV polyprotein. The protease constitutes one functional domain of the bifunctional HCV NS3 (non-structural protein 3). Here, insights regarding the NS3 structure and recently synthesized NS3 inhibitors are reviewed. Interestingly, many NS3 protease inhibitors have taken advantage of an unusual product inhibition by Nterminal products of cleavage at the polyprotein processing sites.

Keywords: Peptidic Inhibitors, Hepatitis C, Serine Protease, Protein, Norvaline, Cyclohexylalanine, carboxy glutamic acid


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy